Intravenous Vitamin C in Adults with Sepsis within the Intensive Care Unit

From the Departments of Drugs (F. Lamontagne, M.-CB, HQM) and Anesthesiology (FD), Université de Sherbrooke, the Division of Pharmacy (BB), Heart de Recherche du CHU de Sherbrooke, Heart Intégré Universitaire de Santé et de Providers Sociaux de l’Estrie – Heart Hospitalier Universitaire de Sherbrooke (F. Lamontagne, M.-HM, JM, FD, E. Carbonneau), and Bishop’s College (DC), Sherbrooke, QC, the Division of Orthopedic Surgical procedure, Division of Surgical procedure (SS), the Division of Drugs (DJC, GHG, BR, TM, MOM, EPB-C., SSK), the Division of Well being Analysis Strategies, Proof, and Impression (DJC, GHG, BR, MOM, LH, EPB-C., FC), and the Inhabitants Well being Analysis Institute (EPB-C.), McMaster College, the Division of Essential Care, St. Joseph’s Healthcare Hamilton (DJC), the Intensive Care Unit, Juravinski Hospital (TM), and Respiratory Remedy, Hamilton Well being Sciences (LH), Hamilton, ON, the Division of Essential Care Drugs, Sunnybrook Well being Sciences Heart (R. Pinto, NM , NKJA), the Interdepartmental Division of Essential Care Drugs, College of Toronto (SM, NKJA), and Sinai Well being System (SM), Toronto, the Departments of Essential Care Drugs (DKH, DMM, MH), Public Well being Sciences (AGD ), and Drugs (DMM), Queen’s College, and Kingston Well being Sciences Heart (AGD, DMM), Kingston, ON, the Division of Pharmacy, Ottawa Hospital (SK), Ottawa Hospital Analysis Institute (SK, IW, R. Porteous) , and the Division of Surgical procedure, College of Ottawa (AJES), Ottawa, ON, the Massawippi Valley Basis, Ayer’s Cliff, QC (DC), the Division of Drugs, Université de Montréal (MC), the Heart Hospitalier de l’Université of Montreal (MC, ML, E. Charbonney), the Analysis Heart of the Sacré-Coeur Hospital of Montreal (E. Charbonney), and the Departments of Drugs and Essential Care, McGill College Well being Heart (JS), Montreal, QC, the Division of Drugs (F. Lauzier) and the Division of Essential Care Drugs, Division of Anesthesiology and Essential Care (F. Lauzier, AFT), Université Laval, the Essential Care Drugs Service (F. Lauzier, AFT), and the Analysis Heart (F. Lauzier, AFT), CHU de Québec – Université Laval, Quebec, QC, the Division of Essential Care Drugs , College of Alberta, Edmonton (OGR, DJK), the Division of Intensive Care, Division of Drugs, CHU Dr. Georges L. Dumont, Moncton, NB (RL), the Division of Surgical procedure, Schulich College of Drugs and Dentistry, Western College, London, ON (TSM), the Division of Intensive Care Drugs, Island Well being Authority, Victoria, BC (GW ), and the Division of Drugs, Halton Healthcare, Oakville, ON (SSK) – all in Canada; the Cardiothoracic and Vascular Intensive Care Unit, Auckland Metropolis Hospital (R. Parke, SPM), and the College of Nursing, College of Auckland (R. Parke), Auckland, the Medical Analysis Institute of New Zealand, Newtown (R. Parke, SPM, PJY), the Intensive Care Unit, Wellington Hospital, Wellington (PJY), and the Division of Surgical Sciences, College of Otago, Dunedin (PT) – all in New Zealand; the Division of Essential Care Drugs, Apollo Hospitals, Chennai, and George Institute for World Well being, New Delhi – each in India (BKTV); the Division of Intensive Care Drugs, Raymond-Poincaré Hospital (Help Publique – Hôpitaux de Paris [AP-HP]), and Fédération Hospitalo-Universitaire SEPSIS, Garches (DA), Institut Nationwide de la Santé et de la Recherche Médicale, College Paris-Saclay Campus UVSQ, Versailles (DA), and Service de Médecine Intensive Réanimation, AP-HP, Hôpitaux Universitaires Henri-Mondor, CARMAS Scientific Analysis Group, and Mondor Institute for Biomedical Analysis, Université Paris Est Créteil, Créteil (AM-D.) – all in France; the Faculty of Drugs, King Saud Bin Abdulaziz College for Well being Sciences, King Abdullah Worldwide Medical Analysis Heart, and the Division of Intensive Care, King Abdulaziz Medical Metropolis, Ministry of Nationwide Guard Well being Affairs – all in Riyadh, Saudi Arabia (YMA); and the Australian and New Zealand Intensive Care Analysis Heart, Monash College, Melbourne, VIC, Australia (R. Parke, SPM, PJY).

Dr. Lamontagne may be contacted at [email protected] or on the Division of Drugs, College of Sherbrooke, 3001 twelfth Ave. N., Sherbrooke, Quebec J1H 5N4, Canada. Dr. Adhikari may be contacted at [email protected] or on the Division of Essential Care Drugs, Sunnybrook Well being Sciences Heart, 2075 Bayview Ave., Room D1.08, Toronto M4N 3M5, Canada.

Leave a Comment

%d bloggers like this: